Zio XT (iRhythm Technologies) is an ambulatory heart monitoring service, designed to detect cardiac arrythmias in people with infrequent symptoms (every 24 hours or longer). It is comprised of the Zio Patch and the Zio Report. The Zio Patch is a self-adhesive, wireless ECG, that is applied to the left upper chest and worn continuously for 2 weeks. The wearer can go about their normal daily activities during monitoring, including showering or bathing because the device is water resistant. After the monitoring period, the Zio Patch is removed and sent to the company via prepaid post. The company analyses the ECG recordings using machine-learned algorithms and distils the results into the Zio Report which is sent electronically to the patient’s clinician.
- Status:
- Suspended
- Technology type:
- Device
- Decision:
- Selected
- Reason for decision:
- Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
- Rationale:
- This will be an update to the existing Guidance (MTG52).
- ID number:
- 591
Project Team
- Project lead
- Farhaan Jamadar
Email enquiries
If you have any queries please email medtech@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 24 January 2023 | Suspended |
| 24 January 2023 | Suspended |
| 24 January 2023 | Suspended |
| 23 January 2023 | Overview - Note added to the project documents |
| 16 January 2023 | Stakeholder registration opens |
| 21 November 2022 | In progress |
| 17 November 2022 | Awaiting development. Status change linked to Topic Selection Decision being set to Selected |
For further information on our processes and methods, please see our CHTE processes and methods manual